RAQA - Eric Richards-VP-Head of Regulatory Affairs-Oncology-Daiichi Sankyo
Prior to joining Daiichi Sankyo in 2017, Eric held a variety of significant leadership roles in Regulatory Affairs with companies such as Pfizer, Glaxso Smith Kline, Astra Zeneca, and Bristol Myers Squibb. Eric has had the opportunity to lead several successful approvals including breakthrough products, and combination products in the US, EU, Australia, China, Japan, and a variety of Emerging Markets Some Nuggets Eric Shares: -How music and discipline translate to the Life Sciences -How failure makes you stronger as a leader -Why the Regulatory Affairs function is closer to drug development than you think -Put yourself in the shoes of patients to help you think outside the box